Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▾	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
JNJ	Johnson & Johnson Manufacturing · Year ended 2025-12-28 · USD	$94.19B	$26.80B	28.5%	32.9%	6.0%	$11.03
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
MRK	Merck & Co., Inc. Manufacturing · Year ended 2025-12-31 · USD	$65.01B	$18.25B	28.1%	34.7%	1.3%	$7.28
PFE	Pfizer Inc Manufacturing · Year ended 2025-12-31 · USD	$62.58B	$7.77B	12.4%	9.0%	-1.6%	$1.36
ABBV	AbbVie Inc. Manufacturing · Year ended 2025-12-31 · USD	$61.16B	$4.23B	6.9%	n/a	8.6%	$2.36
BMY	Bristol Myers Squibb Co Manufacturing · Year ended 2025-12-31 · USD	$48.19B	$7.05B	14.6%	38.2%	-0.2%	$3.46
ABT	Abbott Laboratories Manufacturing · Year ended 2025-12-31 · USD	$44.33B	$6.52B	14.7%	12.5%	5.7%	$3.72
TEVA	Teva Pharmaceutical Industries Ltd Manufacturing · Year ended 2025-12-31 · USD	$17.26B	$1.41B	8.2%	17.8%	4.3%	$1.21
REGN	Regeneron Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.34B	$4.50B	31.4%	14.4%	1.0%	$41.48
VTRS	Viatris Inc Manufacturing · Year ended 2025-12-31 · USD	$14.30B	-$3.51B	-24.6%	-23.9%	-3.0%	-$3.00
VRTX	Vertex Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$12.00B	$3.95B	32.9%	21.2%	8.9%	$15.32
BHC	Bausch Health Companies Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.27B	$120.00M	1.2%	31.8%	6.7%	$0.42
ZTS	Zoetis Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.47B	$2.67B	28.2%	80.2%	2.3%	$6.02
OGN	Organon & Co. Manufacturing · Year ended 2025-12-31 · USD	$6.22B	$187.00M	3.0%	24.9%	-2.9%	$0.72
ONC	BeOne Medicines Ltd. Manufacturing · Year ended 2025-12-31 · USD	$5.34B	$286.93M	5.4%	6.6%	40.2%	$0.19
ELAN	Elanco Animal Health Inc Manufacturing · Year ended 2025-12-31 · USD	$4.71B	-$232.00M	-4.9%	-3.5%	6.2%	-$0.47
JAZZ	Jazz Pharmaceuticals plc Manufacturing · Year ended 2025-12-31 · USD	$4.27B	-$356.15M	-8.3%	-8.2%	4.9%	-$5.84
PRGO	Perrigo Co PLC Manufacturing · Year ended 2025-12-31 · USD	$4.25B	-$1.43B	-33.5%	-48.6%	-2.8%	-$10.29
ALNY	Alnylam Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.71B	$313.75M	8.4%	39.8%	65.2%	$2.33
BMRN	BioMarin Pharmaceutical Inc Manufacturing · Year ended 2025-12-31 · USD	$3.22B	$348.90M	10.8%	5.7%	12.9%	$1.80
UTHR	United Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.18B	$1.33B	41.9%	18.8%	10.6%	$27.86
AMRX	Amneal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02B	$72.06M	2.4%	n/a	8.0%	$0.22
RPRX	Royalty Pharma plc Manufacturing · Year ended 2025-12-31 · USD	$2.38B	$770.95M	32.4%	7.9%	5.1%	$1.78
SRPT	Sarepta Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.20B	-$713.41M	-32.5%	-62.5%	15.6%	-$7.13
PTCT	PTC Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.73B	$682.64M	39.4%	n/a	114.5%	$7.78
PAHC	Phibro Animal Health Corp Manufacturing · Year ended 2026-06-30 · USD	$1.52B	$99.72M	6.6%	25.9%	17.1%	$2.43
ALKS	Alkermes plc. Manufacturing · Year ended 2025-12-31 · USD	$1.48B	$241.66M	16.4%	13.3%	-5.2%	$1.43
INDV	Indivior Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.24B	$210.00M	16.9%	n/a	4.3%	$1.64
PBH	Prestige Consumer Healthcare Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.09B	$190.30M	17.5%	10.1%	-4.3%	$3.91
ACAD	Acadia Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$1.07B	$391.00M	36.5%	31.9%	11.9%	$2.30
MDGL	Madrigal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$958.40M	-$288.28M	-30.1%	-47.8%	432.1%	-$12.85
IONS	Ionis Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$943.71M	-$381.39M	-40.4%	-78.0%	33.8%	-$2.38
ANIP	ANI Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$883.37M	$78.34M	8.9%	14.5%	43.8%	$3.32
HRMY	Harmony Biosciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$868.45M	$158.69M	18.3%	18.2%	21.5%	$2.71
ARWR	Arrowhead Pharmaceuticals, Inc. Manufacturing · Year ended 2025-09-30 · USD	$829.45M	$30.11M	3.6%	6.0%	n/m	-$0.01
COLL	Collegium Pharmaceutical, Inc Manufacturing · Year ended 2025-12-31 · USD	$780.57M	$62.87M	8.1%	20.8%	23.6%	$1.73
CORT	Corcept Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$761.41M	$99.65M	13.1%	15.4%	12.8%	$0.82
EBS	Emergent BioSolutions Inc. Manufacturing · Year ended 2025-12-31 · USD	$742.90M	$52.60M	7.1%	10.1%	-28.8%	$0.93
PCRX	Pacira BioSciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$726.41M	$7.03M	1.0%	1.0%	3.6%	$0.16
AMPH	Amphastar Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$719.89M	$98.09M	13.6%	12.4%	-1.7%	$2.03
SUPN	Supernus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$718.95M	-$38.55M	-5.4%	-3.6%	8.6%	-$0.68
KNSA	Kiniksa Pharmaceuticals International, plc Manufacturing · Year ended 2025-12-31 · USD	$677.56M	$59.01M	8.7%	10.4%	60.1%	$0.75
RARE	Ultragenyx Pharmaceutical Inc. Manufacturing · Year ended 2025-12-31 · USD	$673.00M	-$575.00M	-85.4%	n/a	20.2%	-$5.83
AXSM	Axsome Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$638.50M	-$183.17M	-28.7%	-207.5%	65.5%	-$3.68
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
OPK	Opko Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$606.88M	-$225.68M	-37.2%	-17.8%	-14.9%	-$0.30
INSM	Insmed Inc Manufacturing · Year ended 2025-12-31 · USD	$606.42M	-$1.28B	-210.5%	-172.8%	66.7%	-$6.42
ORGO	Organogenesis Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$564.17M	$37.03M	6.6%	12.3%	17.0%	$0.15
HCM	HUTCHMED (China) Ltd Manufacturing · Year ended 2025-12-31 · USD	$548.51M	$456.91M	83.3%	36.5%	-13.0%	$0.52
MIRM	Mirum Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$521.31M	-$23.36M	-4.5%	-7.4%	54.7%	-$0.47
BBIO	BridgeBio Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$502.08M	-$732.94M	-146.0%	n/a	126.3%	-$3.78
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
NATR	Nature's Sunshine Products Inc Manufacturing · Year ended 2025-12-31 · USD	$480.14M	$20.45M	4.3%	12.7%	5.7%	$1.06
ZLAB	Zai Lab Ltd Manufacturing · Year ended 2025-12-31 · USD	$457.18M	-$175.54M	-38.4%	-24.5%	15.0%	-$0.16
INVA	Innoviva, Inc. Manufacturing · Year ended 2025-12-31 · USD	$411.33M	$271.17M	65.9%	23.1%	14.7%	$3.30
ARDX	Ardelyx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$407.32M	-$61.60M	-15.1%	-36.9%	22.1%	-$0.26
SVA	Sinovac Biotech Ltd Manufacturing · Year ended 2025-12-31 · USD	$386.01M	-$198.84M	-51.5%	-3.1%	6.8%	-$0.83
ARQT	Arcutis Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$372.07M	-$16.14M	-4.3%	-8.5%	123.4%	-$0.13
MNKD	MannKind Corp Manufacturing · Year ended 2025-12-31 · USD	$348.97M	$5.86M	1.7%	n/a	22.2%	$0.02
CRMD	CorMedix Inc. Manufacturing · Year ended 2025-12-31 · USD	$311.71M	$163.06M	52.3%	40.2%	617.0%	$2.04
EOLS	Evolus, Inc. Manufacturing · Year ended 2025-12-31 · USD	$297.18M	-$51.64M	-17.4%	n/a	11.6%	-$0.80
IRWD	Ironwood Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$296.15M	$24.02M	8.1%	n/a	-15.7%	$0.15
XERS	Xeris Biopharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$291.85M	$554.0K	0.2%	4.0%	43.7%	$0.00
HROW	Harrow, Inc. Manufacturing · Year ended 2025-12-31 · USD	$272.30M	-$5.14M	-1.9%	-9.8%	36.4%	-$0.14
VREOF	Vireo Growth Inc. Manufacturing · Year ended 2025-12-31 · USD	$268.77M	-$68.11M	-25.3%	-22.2%	170.4%	-$0.09
LGND	Ligand Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$268.09M	$124.45M	46.4%	12.2%	60.4%	$6.13
ARVN	Arvinas, Inc. Manufacturing · Year ended 2025-12-31 · USD	$262.60M	-$80.80M	-30.8%	-18.6%	-0.3%	-$1.14
SDGR	Schrodinger, Inc. Manufacturing · Year ended 2025-12-31 · USD	$255.87M	-$103.27M	-40.4%	-28.4%	23.3%	-$1.41
RCUS	Arcus Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$247.00M	-$353.00M	-142.9%	-55.9%	-4.3%	-$3.29
KROS	Keros Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$244.06M	$87.01M	35.7%	28.7%	n/m	$2.30
AKBA	Akebia Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$236.20M	-$5.34M	-2.3%	-16.4%	47.5%	-$0.02
ANAB	Anaptysbio, Inc Manufacturing · Year ended 2025-12-31 · USD	$234.60M	-$13.23M	-5.6%	-35.6%	157.0%	-$0.46
PBYI	Puma Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$228.37M	$31.11M	13.6%	23.9%	-0.9%	$0.61
IDYA	IDEAYA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$218.71M	-$113.70M	-52.0%	-11.1%	n/m	-$1.28
VNDA	Vanda Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$216.10M	-$220.47M	-102.0%	-67.4%	8.7%	-$3.74
AMRN	Amarin Corp PLC Manufacturing · Year ended 2025-12-31 · USD	$213.65M	-$38.80M	-18.2%	-8.4%	-6.5%	-$0.09
RYTM	Rhythm Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$189.76M	-$196.54M	-103.6%	-141.3%	45.8%	-$3.11
MRVI	Maravai Lifesciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$185.74M	-$130.77M	-70.4%	-61.6%	-28.3%	-$0.90
STOK	Stoke Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$184.42M	-$6.88M	-3.7%	-2.0%	404.5%	-$0.12
LFVN	Lifevantage Corp Manufacturing · Year ended 2026-06-30 · USD	$182.59M	$5.07M	2.8%	15.1%	-20.1%	$0.40
CYRX	Cryoport, Inc. Manufacturing · Year ended 2025-12-31 · USD	$176.18M	$78.30M	44.4%	15.6%	12.4%	$1.40
PHAT	Phathom Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$175.11M	-$221.25M	-126.3%	n/a	216.9%	-$3.03
SNDX	Syndax Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$172.35M	-$285.42M	-165.6%	-441.6%	627.8%	-$3.29
LQDA	Liquidia Corp Manufacturing · Year ended 2025-12-31 · USD	$158.32M	-$68.92M	-43.5%	-154.0%	n/m	-$0.80
HRTX	Heron Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$154.90M	-$20.20M	-13.0%	-140.9%	7.4%	-$0.12
MGNX	Macrogenics Inc Manufacturing · Year ended 2025-12-31 · USD	$149.50M	-$74.62M	-49.9%	-134.2%	-0.3%	-$1.18
ELTP	Elite Pharmaceuticals Inc Manufacturing · Year ended 2026-03-31 · USD	$148.87M	$44.87M	30.1%	45.4%	77.1%	$0.03
KPTI	Karyopharm Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$146.07M	-$196.04M	-134.2%	n/a	0.6%	-$17.93
LFCR	Lifecore Biomedical, Inc. Manufacturing · Year ended 2025-05-25 · USD	$128.87M	-$38.72M	-30.0%	n/m	0.5%	-$1.27
XNCR	Xencor Inc Manufacturing · Year ended 2025-12-31 · USD	$125.58M	-$91.92M	-73.2%	-14.5%	13.7%	-$1.24
GYRE	Gyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$116.59M	$9.88M	8.5%	9.3%	10.2%	$0.02
URGN	UroGen Pharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$109.79M	-$153.49M	-139.8%	n/a	21.4%	n/a
TBPH	Theravance Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$107.46M	$105.89M	98.5%	35.7%	66.9%	$2.06
ZVRA	Zevra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$106.47M	$83.23M	78.2%	53.8%	350.9%	$1.35
ZYME	Zymeworks Inc. Manufacturing · Year ended 2025-12-31 · USD	$105.97M	-$81.13M	-76.6%	-30.2%	38.9%	-$1.08
SIGA	Siga Technologies Inc Manufacturing · Year ended 2025-12-31 · USD	$94.57M	$23.28M	24.6%	11.7%	-31.8%	$0.32
CYTK	Cytokinetics Inc Manufacturing · Year ended 2025-12-31 · USD	$88.04M	-$784.96M	-891.6%	n/a	376.6%	-$6.54
LAB	Standard Biotools Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.33M	-$74.90M	-87.8%	-17.7%	-6.2%	-$0.20
SPRY	ARS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$84.28M	-$171.30M	-203.3%	-149.9%	-5.5%	-$1.74
NRIX	Nurix Therapeutics, Inc. Manufacturing · Year ended 2025-11-30 · USD	$83.98M	-$264.46M	-314.9%	-49.1%	54.0%	-$3.05

Rows per page: 25 50100